{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:58Z","timestamp":1789429318287,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Fungal Biol."],"abstract":"<jats:p>The antimicrobial peptide (AMP) circularized bacteriocin enterocin AS-48 produced by <jats:italic>Enterococcus<\/jats:italic> sp. exhibits broad-spectrum antibacterial activity via dimer insertion into the plasma membrane to form membrane pore structures, compromising membrane integrity and leading to bactericidal activity. A specific alpha-helical region of enterocin AS-48 has been shown to be responsible for the membrane-penetrating activity of the peptide. The canon syn-enterocin peptide library, generated using rational design techniques to have ninety-five synthetic peptide variants from the truncated, linearized, membrane-interacting domain of enterocin AS-48, was screened against three clinically relevant fungal strains: <jats:italic>Cryptococcus neoformans<\/jats:italic>, <jats:italic>Candida albicans<\/jats:italic>, and <jats:italic>Candida auris<\/jats:italic> for potential antifungal activity. Twelve peptides exhibited antifungal activity against <jats:italic>C. neoformans<\/jats:italic>, and two peptides exhibited activity against <jats:italic>C. albicans<\/jats:italic>. The fourteen active antifungal peptides were minimally cytotoxic to an immortalized human keratinocyte cell line (HaCats). Four select peptides were identified with minimum inhibitory concentrations (MICs) below 8 \u00b5M against <jats:italic>C. neoformans<\/jats:italic>. In 36-hour cell growth tests with these fungicidal peptides, fungicidal peptide no. 32 displayed inhibitory properties comparable to the leading antifungal medication fluconazole against <jats:italic>C. neoformans<\/jats:italic>. Screening of peptide no. 32 against a deletion library of <jats:italic>C. neoformans<\/jats:italic> mutants revealed that the mechanism of action of peptide no. 32 may relate to multivesicular bodies (MVBs) or polysaccharide capsule targeting. These findings importantly demonstrate that naturally derived AMPs produced by bacteria can be sourced, engineered, and modified to exhibit potent antifungal activity. Our results will contribute to the development of broad treatment alternatives to fungal infections and lend themselves to direct implications for possible treatment options for <jats:italic>C. neoformans<\/jats:italic> infections.<\/jats:p>","DOI":"10.3389\/ffunb.2024.1506315","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:24:44Z","timestamp":1734589484000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Minimal domain peptides derived from enterocins exhibit potent antifungal activity"],"prefix":"10.3389","volume":"5","author":[{"given":"Dorrian G.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Schorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Winski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbi L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Arsenault","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe H.","family":"Santiago-Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.bbamem.2011.06.020","article-title":"Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor","volume":"1808","author":"Ashkenazi","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jof8010058","article-title":"Fungal infections other than invasive aspergillosis in COVID-19 patients","volume":"8","author":"Basile","year":"2022","journal-title":"J. Fungi."},{"key":"B3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J. Fungi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/0929866526666190822165812","article-title":"Mini review on antimicrobial peptides, sources, mechanism and recent applications","volume":"27","author":"Boparai","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"B6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/21505594.2018.1431087","article-title":"The capsule of Cryptococcus neoformans","volume":"10","author":"Casadevall","year":"2019","journal-title":"Virulence."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1128\/IAI.00089-06","article-title":"CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans","volume":"74","author":"Chang","year":"2006","journal-title":"Infect. Immun."},{"key":"B8","unstructured":"Cohen\n              D.\n            \n          \n          Created in biorender\n          \n          2024"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02658-22","article-title":"Rationally designed minimal bioactive domains of AS-48 bacteriocin homologs possess potent antileishmanial properties","author":"Corman","year":"2022","journal-title":"Microbiol. Spectr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1074\/jbc.RA119.012251","article-title":"Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe","volume":"295","author":"Crawford","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008921","article-title":"Candida auris: Epidemiology, biology, antifungal resistance, and virulence","volume":"16","author":"Du","year":"2020","journal-title":"PloS Pathog."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad023","article-title":"After a century of nisin research-where are we now","volume":"47","author":"Field","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41429-018-0032-4","article-title":"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48","volume":"71","author":"Fields","year":"2018","journal-title":"J. Antibiotics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1021\/bi025856q","article-title":"Mutational analysis of the role of tryptophan residues in an antimicrobial peptide","volume":"41","author":"Fimland","year":"2002","journal-title":"Biochemistry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: Form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1128\/EC.00013-09","article-title":"Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans","volume":"8","author":"Grijpstra","year":"2009","journal-title":"Eukaryot Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.devcel.2011.05.015","article-title":"The ESCRT pathway","volume":"21","author":"Henne","year":"2011","journal-title":"Dev. Cell."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jof9060667","article-title":"Invasive fungal infections associated with COVID-19","volume":"9","author":"Hlaing","year":"2023","journal-title":"J. Fungi"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1128\/IAI.01037-12","article-title":"Cryptococcus neoformans requires the ESCRT protein vps23 for iron acquisition from heme, for capsule formation, and for virulence","volume":"81","author":"Hu","year":"2013","journal-title":"Infect. Immun."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.658329","article-title":"Retrospective analysis of the clinical characteristics of candida auris infection worldwide from 2009 to 2020","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1021\/acs.jmedchem.5b01264","article-title":"A designed tryptophan- and lysine\/arginine-rich antimicrobial peptide with therapeutic potential for clinical antibiotic-resistant candida albicans vaginitis","volume":"59","author":"Jin","year":"2016","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1128\/EC.00120-07","article-title":"Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection","volume":"6","author":"Jong","year":"2007","journal-title":"Eukaryot Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1016\/j.cell.2021.05.042","article-title":"PspA adopts an ESCRT-III-like fold and remodels bacterial membranes","volume":"184","author":"Junglas","year":"2021","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.bioteChadv.2018.10.007","article-title":"Microbial production of bacteriocins: Latest research development and applications","volume":"36","author":"Juturu","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: The silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microbial Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens10020165","article-title":"The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance","volume":"10","author":"Kowalska-Krochmal","year":"2021","journal-title":"Pathogens."},{"key":"B30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ajhp\/48.4.827","article-title":"Fluconazole: a new antifungal agent","volume":"10","author":"Kowalsky","year":"1991","journal-title":"Clin. Pharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in candida albicans and beyond","volume":"121","author":"Lee","year":"2021","journal-title":"Chem. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1016\/j.cell.2021.05.041","article-title":"Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily","volume":"184","author":"Liu","year":"2021","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111401","article-title":"Mechanism of antimicrobial peptides: Antimicrobial, anti-inflammatory and antibiofilm activities","volume":"22","author":"Luo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3175","article-title":"AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity","volume":"25","author":"Madanchi","year":"2019","journal-title":"J. Pept. Sci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.105039","article-title":"COVID-19 and Fungal infections: a double debacle","volume":"24","author":"Mina","year":"2022","journal-title":"Microbes Infect."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1016\/j.febslet.2008.08.018","article-title":"Characterization of linear forms of the circular enterocin AS-48 obtained by limited proteolysis","volume":"582","author":"Montalb\u00e1n-L\u00f3pez","year":"2008","journal-title":"FEBS Lett."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.668632","article-title":"Antimicrobial peptides: A new hope in biomedical and pharmaceutical fields","volume":"11","author":"Moretta","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.peptides.2013.07.025","article-title":"Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against gram-positive staphylococcus aureus","volume":"48","author":"Morita","year":"2013","journal-title":"Peptides (NY)."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12060633","article-title":"The ESCRT machinery: remodeling, repairing, and sealing membranes","volume":"12","author":"Olmos","year":"2022","journal-title":"Membranes (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-021-00238-z","article-title":"CO2 enhances the formation, nutrient scavenging and drug resistance properties of C","volume":"7","author":"Pentland","year":"2021","journal-title":"albicans biofilms. NPJ Biofilms Microbiomes."},{"key":"B42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.cellbio.23.090506.123319","article-title":"Biogenesis and function of multivesicular bodies","volume":"23","author":"Piper","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"22","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105521","article-title":"A holistic review on Cryptococcus neoformans","volume":"166","author":"Rathore","year":"2022","journal-title":"Microb. Pathog."},{"key":"B46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","article-title":"Antifungal drug resistance: evolution, mechanisms and impact","volume":"45","author":"Revie","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: A wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PloS Negl. Trop. Dis."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.589666","article-title":"Synthetic peptide libraries designed from a minimal alpha-helical domain of AS-48-bacteriocin homologs exhibit potent antibacterial activity","volume":"11","author":"Ross","year":"2020","journal-title":"Front. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","article-title":"The ESCRT machinery","volume":"22","author":"Schmidt","year":"2012","journal-title":"Curr. Biol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"B51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","article-title":"Pulmonary cryptococcosis: A review of pathobiology and clinical aspects","volume":"57","author":"Setianingrum","year":"2019","journal-title":"Med. Mycol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/mmbr.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodcont.2020.107178","article-title":"Anti-yeast activity and characterisation of synthetic radish peptides Rs-AFP1 and Rs-AFP2 against food spoilage yeast: Synthetic radish peptides against food spoilage yeast","volume":"113","author":"Shwaiki","year":"2020","journal-title":"Food Control."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s00018-020-03736-z","article-title":"Mechanisms of fungal dissemination","volume":"78","author":"Strickland","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/foods11193145","article-title":"Use of bacteriocins and bacteriocinogenic beneficial organisms in food products: benefits, challenges, concerns","volume":"11","author":"Todorov","year":"2022","journal-title":"Foods"},{"key":"B56","volume-title":"WHO fungal priority pathogens list","year":""},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10080956","article-title":"Design, synthesis and antifungal activity of stapled aurein1.2 peptides","volume":"10","author":"Zheng","year":"2021","journal-title":"Antibiotics"}],"container-title":["Frontiers in Fungal Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2024.1506315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:24:49Z","timestamp":1734589489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ffunb.2024.1506315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":57,"alternative-id":["10.3389\/ffunb.2024.1506315"],"URL":"https:\/\/doi.org\/10.3389\/ffunb.2024.1506315","relation":{},"ISSN":["2673-6128"],"issn-type":[{"value":"2673-6128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"article-number":"1506315"}}